NCT02374450 - A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine | Biotech Hunter

Enrollment

36,366

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

August 2, 2022

Study Completion Date

August 2, 2022

Conditions

Malaria

Interventions

PROCEDURE

Blood collection

For all hospitalised children suspected of having an AESI or meningitis, a sample of 5 ml of whole blood was collected and the serum was stored.

Trial Locations (5)

GSK Investigational Site, Kisumu

GSK Investigational Site, Ouagadougou

GSK Investigational Site, PO BOX 02 Nouna

GSK Investigational Site, Kintampo

GSK Investigational Site, Navrongo